Third Harmonic Bio Inc [THRD] stock is trading at $5.16, up 0.58%. An important factor to consider is whether the stock is rising or falling in short-term value. The THRD shares have gain 48.70% over the last week, with a monthly amount glided 46.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Third Harmonic Bio Inc [NASDAQ: THRD] stock has seen the most recent analyst activity on March 28, 2025, when Stifel downgraded its rating to a Hold and also revised its price target to $5 from $23. Previously, Morgan Stanley downgraded its rating to Equal-Weight on February 12, 2025, and dropped its price target to $5. On February 11, 2025, downgrade downgraded it’s rating to Mkt Perform. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $20 on August 09, 2024. Stifel initiated its recommendation with a Buy and recommended $23 as its price target on June 18, 2024. Raymond James started tracking with a Outperform rating for this stock on June 07, 2024, and assigned it a price target of $18. In a note dated December 16, 2022, Jefferies downgraded an Hold rating on this stock and revised its target price from $30 to $3.60.
Third Harmonic Bio Inc [THRD] stock has fluctuated between $3.18 and $16.94 over the past year. Currently, Wall Street analysts expect the stock to reach $16.15 within the next 12 months. Third Harmonic Bio Inc [NASDAQ: THRD] shares were valued at $5.16 at the most recent close of the market. An investor can expect a potential return of 212.98% based on the average THRD price forecast.
Analyzing the THRD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.17 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.12 points at the first support level, and at 5.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.18, and for the 2nd resistance point, it is at 5.21.
Ratios To Look Out For
For context, Third Harmonic Bio Inc’s Current Ratio is 40.87. On the other hand, the Quick Ratio is 40.87, and the Cash Ratio is 40.1.
Transactions by insiders
Recent insider trading involved Conner Edward R., Chief Medical Officer, that happened on Nov 08 ’24 when 2117.0 shares were sold. See Explanation of Responses, BVF PARTNERS L P/IL completed a deal on Oct 29 ’24 to sell 1.0 million shares. Meanwhile, Chief Medical Officer Conner Edward R. sold 2673.0 shares on Oct 28 ’24.
